Depreciation in USD of Marker Therapeutics, Inc. from Q2 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Marker Therapeutics, Inc. quarterly/annual Depreciation history and change rate from Q2 2011 to Q1 2023.
  • Marker Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2023 was $800K, a 33.3% increase year-over-year.
  • Marker Therapeutics, Inc. Depreciation for the twelve months ending 31 Mar 2023 was $800K, a 63.6% decline year-over-year.
  • Marker Therapeutics, Inc. annual Depreciation for 2022 was $600K, a 71.4% decline from 2021.
  • Marker Therapeutics, Inc. annual Depreciation for 2021 was $2.1M, a 320% increase from 2020.
  • Marker Therapeutics, Inc. annual Depreciation for 2020 was $500K, a 400% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Marker Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $800K $800K +$200K +33.3% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $600K -$1.4M -$1.9M -380% 01 Oct 2022 31 Dec 2022 10-Q 15 May 2023
Q3 2022 $2.5M $800K +$200K +33.3% 01 Jul 2022 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $2.3M $600K +$100K +20% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $2.2M $600K +$100K +20% 01 Jan 2022 31 Mar 2022 10-Q 13 May 2022
Q4 2021 $2.1M $500K +$230K +85.2% 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 $1.87M $600K +$500K +500% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $1.37M $500K +$400K +400% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $970K $500K +$470K +1567% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022
Q4 2020 $500K $270K +$240K +800% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022
Q3 2020 $260K $100K +$70K +233% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $190K $100K +$71K +245% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021
Q1 2020 $119K $30K +$19K +173% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021
Q4 2019 $100K $30K 01 Oct 2019 31 Dec 2019 10-K 09 Mar 2021
Q3 2019 $30K 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $29K 01 Apr 2019 30 Jun 2019 10-Q 09 Aug 2019
Q1 2019 $11K 01 Jan 2019 31 Mar 2019 10-Q 10 May 2019
Q2 2012 $0 $0 01 Apr 2012 30 Jun 2012 10-Q/A 12 Sep 2012
Q2 2011 $0 01 Apr 2011 30 Jun 2011 10-Q/A 12 Sep 2012

Marker Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $600K -$1.5M -71.4% 01 Jan 2022 31 Dec 2022 10-Q 15 May 2023
2021 $2.1M +$1.6M +320% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023
2020 $500K +$400K +400% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022
2019 $100K +$100K 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021
2018 $0 01 Jan 2018 31 Dec 2018 10-Q 12 Nov 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.